Showing results (41-50 of 696) with videos related to

Sort By:
Pageof 70
BMJ Open|September 21, 2024
Cohort profile: the PRIMETIME 1 (PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy) cohort - a longitudinal Danish nationwide study of individuals with diabetes and a performed kidney biopsyKarina Haar Jensen, Vanja Kosjerina, Ditte Hansen, et al.
BMJ Open Diabetes Research & Care|May 26, 2026
Mapping shared genetic determinants of eGFR and albuminuria with a focus on type 2 diabetes: a large-scale European studyCilia Naaman, Frederik Persson, Thomas Kümler, et al.
Diabetes, Obesity & Metabolism|October 19, 2016
The effect of liraglutide on renal function: A randomized clinical trialBernt J von Scholten, Frederik Persson, Signe Rosenlund, et al.
Journal of Diabetes and Its Complications|August 14, 2022
Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetesHenrik Ø Hjortkjær, Frederik Persson, Simone Theilade, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 17, 2018
Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetesSascha Pilemann-Lyberg, Tine Willum Hansen, Frederik Persson, et al.
Diabetes, Obesity & Metabolism|February 3, 2022
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrologySimke W Waijer, Michele Provenzano, Skander Mulder, et al.
Diabetes, Obesity & Metabolism|September 18, 2023
Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled studySuvanjaa Sivalingam, Victor Soendergaard Wasehuus, Viktor Rotbain Curovic, et al.
Plos One|July 30, 2021
Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetesElisabeth Buur Stougaard, Signe Abitz Winther, Hanan Amadid, et al.
Diabetes, Obesity & Metabolism|October 22, 2021
The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trialsEmilie H Zobel, Bernt Johan von Scholten, Tine W Hansen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 9, 2008
Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) studyFrederik Persson, Peter Rossing, Peter Hovind, et al.
Pageof 70